Company to Discuss Upcoming Phase 1/2 Study of Twice Per Year Treatment for AMD
Continue ReadingAuthor: Presse
Akers Biosciences Announces Board Changes
Experienced directors with medical device and financial backgrounds to steer the Company through next phase of…
Continue Reading
New Look Vision Group Inc. to Hold Second Quarter 2017 Results Conference Call
MONTREAL, QUEBEC -- (Marketwired) -- 08/07/17 -- New Look Vision Group Inc. (TSX: BCI) ("New Look")…
Continue Reading
Freddie Mac Issues Dodd-Frank Stress Test Results
MCLEAN, VA -- (Marketwired) -- 08/07/17 -- Freddie Mac (OTCQB: FMCC) today issued the company--s stress…
Continue ReadingMedovex Corporation DenerveX System Completes First Human Case in Italy
Professor Dr. Pier Vittorio Nardi, Neurosurgeon at the University La Sapienza in Rome, Italy Performs 2…
Continue Reading
Polsinelli Represents FelCor in Two Multimillion Dollar Hotel Deals in New York
NEW YORK, NY -- (Marketwired) -- 08/07/17 -- Am Law 100 firm Polsinelli announced today it…
Continue Reading
Q Therapeutics Expands Board of Directors With Appointment of Dr. Tom Parks as Independent Member
Appointment Adds World Class Expertise in Neuro-Cellular Interactions and functions
Continue Reading
IDW Entertainment Introduces IDW Digital Studio — Next Generation Digital Entertainment
Pioneering Initiative Maximizes IDW Franchises Across Multiple Digital Platforms
Continue Reading
NEMUS Bioscience Announces Presentation of CBD-analogue (NB2222) Ocular Data at the AAPS 2017 Annual Meeting
Data shows NB2222 exhibits superior ocular bioavailability versus plant-derived CBD
Continue ReadingMarathon Patent Group, Inc. to Announce Second Quarter Financial Results on August 14, 2017
LOS ANGELES, CA -- (Marketwired) -- 08/07/17 -- (NASDAQ: MARA) ("Marathon" or the "Company"), an IP…
Continue Reading